For the quarter ended June 2025, Aspen Aerogels (ASPN Quick QuoteASPN - Free Report) reported revenue of $78.02 million, down 33.8% over the same period last year. EPS came in at -$0.04, compared to $0.21 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $72.07 million, representing a surprise of +8.26%. The company delivered an EPS surprise of +66.67%, with the consensus EPS estimate being -$0.12.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Aspen Aerogels performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue- Energy Industrial: $22.8 million compared to the $33.49 million average estimate based on two analysts. The reported number represents a change of -38.2% year over year.
• Revenue- Thermal Barrier: $55.2 million versus the two-analyst average estimate of $37.69 million. The reported number represents a year-over-year change of -31.7%.
• Gross Profit- Thermal Barrier: $17.01 million versus the two-analyst average estimate of $7.61 million.
• Gross Profit- Energy Industrial: $8.31 million compared to the $10.98 million average estimate based on two analysts.

View all Key Company Metrics for Aspen Aerogels here>>>

Shares of Aspen Aerogels have returned +8.1% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.